Clincosm LogoSign in Get a demo

pancreatic cancer

Showing NaN - NaN of 104
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Breast Cancer, Pancreatic Cancer Trial in United States (SON-DP)

Recruiting
  • Solid Tumor
  • +4 more
  • Gilbert, Arizona
  • +4 more
Aug 4, 2023

Pancreatic Cancer, Ovarian Cancer, Adenocarcinoma Trial in Houston (TROP2-CAR-NK, Cyclophosphamide, Fludarabine)

Not yet recruiting
  • Pancreatic Cancer
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 27, 2023

Pancreatic Cancer Trial in Houston (Enhanced Usual Care, Tele-supervised resistance exercises)

Not yet recruiting
  • Pancreatic Cancer
  • Enhanced Usual Care
  • Tele-supervised resistance exercises
  • Houston, Texas
    M D Anderson Cancer Center
Apr 20, 2023

Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +15 more
  • A2B530
  • xT-Onco with HLA-LOH Assay
  • Duarte, California
  • +6 more
Feb 10, 2023

Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer Trial in United States (GRT-C903, GRT-R904, nivolumab)

Recruiting
  • Non-Small Cell Lung Cancer
  • +4 more
  • GRT-C903
  • +3 more
  • Phoenix, Arizona
  • +13 more
Jan 30, 2023

Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in Worldwide (zolbetuximab,

Recruiting
  • Pancreatic Cancer
  • +2 more
  • Goodyear, Arizona
  • +131 more
Jan 30, 2023

Non Small Cell Lung Cancer, Pancreatic Cancer, Colorectal Cancer Trial in United States (BMF-219)

Recruiting
  • Non Small Cell Lung Cancer
  • +16 more
  • Goodyear, Arizona
  • +10 more
Jan 24, 2023

Solid Tumor, Non Small Cell Lung Cancer, Pancreatic Cancer Trial in Israel, United States (CM-24 and Nivolumab - Dose

Recruiting
  • Solid Tumor
  • +6 more
  • CM-24 and Nivolumab - Dose Escalation
  • +4 more
  • Scottsdale, Arizona
  • +10 more
Jan 17, 2023

Gynecologic Cancer, Ovary Cancer, Pancreatic Cancer Trial in Houston (Free genetic testing and counseling group, IGNITE-TX

Not yet recruiting
  • Gynecologic Cancer
  • +8 more
  • Free genetic testing and counseling group
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Center
Jan 11, 2023

NSCLC, Pancreatic Cancer, Colorectal Cancer Trial in Canada, United States (PF-06946860, Placebo for PF-06946860)

Completed
  • Non-small Cell Lung Cancer
  • +9 more
  • Little Rock, Arkansas
  • +32 more
Dec 12, 2022

Colorectal Cancer, NSCLC, Triple Negative Breast Cancer Trial in Spain, United Kingdom, United States (GEN1029

Terminated
Has Results
  • Colorectal Cancer
  • +6 more
  • GEN1029 (HexaBody®-DR5/DR5)
  • New Haven, Connecticut
  • +5 more
Nov 11, 2022

Pancreatic Cancer, Breast Cancer, Hepatocellular Carcinoma Trial in Houston (Piflufolastat F18)

Recruiting
  • Pancreatic Cancer
  • +2 more
  • Piflufolastat F18
  • Houston, Texas
    MD Anderson Cancer Center
Nov 28, 2022

Advanced Solid Tumor, Gynecologic Cancer, Breast Cancer Trial in United States (PY159 Single agent dose level 1, PY159 Single

Recruiting
  • Advanced Solid Tumor
  • +7 more
  • PY159 Single agent dose level 1
  • +17 more
  • San Francisco, California
  • +11 more
Nov 3, 2022

Squamous Cell Carcinoma of Head and Neck, NSCLC, Hepatocellular Carcinoma Trial in Worldwide (KY1044, KY1044 and atezolizumab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +11 more
  • New Haven, Connecticut
  • +12 more
Nov 3, 2022

Breast Cancer, Ovarian Cancer, Non Small Cell Lung Cancer Trial in San Francisco, Denver, San Antonio (P-MUC1C-ALLO1 CAR-T

Recruiting
  • Breast Cancer
  • +8 more
  • San Francisco, California
  • +4 more
Oct 26, 2022

Pancreatic Cancer Trial in Australia, Spain, United States (nal-IRI, 5 fluorouracil, Leucovorin)

Completed
Has Results
  • Pancreatic Cancer
  • Mobile, Alabama
  • +35 more
Oct 7, 2022

Pancreatic Cancer Trial in Houston (genetic, drug, biological)

Recruiting
  • Pancreatic Cancer
  • delolimogene mupadenorepvec
  • +3 more
  • Houston, Texas
  • +1 more
Sep 16, 2022

Pancreatic Cancer Trial in United States (drug, radiation, procedure)

Active, not recruiting
  • Pancreatic Cancer
  • Aurora, Colorado
  • +9 more
Sep 7, 2022

Biomarkers in Subjects With Untreated Solid Tumors

Completed
  • Breast Cancer
  • +12 more
  • Blood Sample Collection
  • Phoenix, Arizona
  • +118 more
Aug 31, 2022

Characterization and Type 3c Diabetes Mellitus Secondary to

Recruiting
  • Pancreatic Cancer
  • +2 more
  • Data Management and Monitoring
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 25, 2022

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Solid Tumor, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Canada, Spain, United States (BNT141,

Recruiting
  • Solid Tumor
  • +7 more
  • BNT141
  • +2 more
  • Duarte, California
  • +10 more
Aug 23, 2022

Non Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (Selpercatinib)

Available
  • Non Small Cell Lung Cancer
  • +6 more
  • Goodyear, Arizona
  • +67 more
Aug 17, 2022

Pancreatic Adenocarcinoma, Pancreatic Cancer Trial in Houston (Autologous DC vaccine)

Recruiting
  • Pancreatic Adenocarcinoma
  • Pancreatic Cancer
  • Autologous DC vaccine
  • Houston, Texas
  • +2 more
Aug 17, 2022

Subjects Treated With Autologous T Cells Using Sleeping Beauty

Not yet recruiting
  • Gynecologic Cancer
  • +9 more
  • Neoantigen specific TCR-T cell drug product
  • Houston, Texas
    MD Anderson Cancer Center
Jul 27, 2022